Literature DB >> 32126045

Extended depth-of-focus technology in intraocular lenses.

Thomas Kohnen1, Rajaraman Suryakumar.   

Abstract

The extended depth-of-focus (EDOF) intraocular lens (IOL) is an emerging technology that is designed to improve range of vision, especially at intermediate distances. In this review, we describe the clinical performance of 4 emerging EDOF IOL technologies; that is, small aperture, bioanalogic, diffractive optics, and nondiffractive optical manipulations. The American Academy of Ophthalmology generated a consensus statement for EDOF IOLs that provided benchmarks and recommendations for classifying an implant as an EDOF IOL as well as standardized testing criteria for evaluating performance. Although many types of EDOF technologies are being developed, there are important differences in their performance that require further testing and evaluation.

Mesh:

Year:  2020        PMID: 32126045     DOI: 10.1097/j.jcrs.0000000000000109

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  12 in total

1.  Clinical Performance of Extended Depth of Focus (EDOF) Intraocular Lenses - A Retrospective Comparative Study of Mini Well Ready and Symfony.

Authors:  Katarzyna Ewa Nowik; Kamil Nowik; Piotr Kanclerz; Jacek Paweł Szaflik
Journal:  Clin Ophthalmol       Date:  2022-05-26

2.  Patient Satisfaction and Visual Performance in Patients with Ocular Pathology after Bilateral Implantation of a New Extended Depth of Focus Intraocular Lens.

Authors:  Laureano A Rementería-Capelo; Pilar Lorente; Virginia Carrillo; José M Sánchez-Pina; Javier Ruiz-Alcocer; Inés Contreras
Journal:  J Ophthalmol       Date:  2022-04-28       Impact factor: 1.974

Review 3.  Comparison of Patient Outcomes following Implantation of Trifocal and Extended Depth of Focus Intraocular Lenses: A Systematic Review and Meta-Analysis.

Authors:  Yining Guo; Yinhao Wang; Ran Hao; Xiaodan Jiang; Ziyuan Liu; Xuemin Li
Journal:  J Ophthalmol       Date:  2021-12-29       Impact factor: 1.909

4.  Clinical Outcomes, Contrast Sensitivity, Reading Performance and Patient Satisfaction Following Bilateral Implantation of AT LARA 829MP EDoF IOLs.

Authors:  Sri Ganesh; Sheetal Brar; Nikhil Rp; Dishitha Rathod
Journal:  Clin Ophthalmol       Date:  2021-10-21

5.  Clinical Outcomes and Quality of Vision Associated with Bilateral Implantation of a Wavefront Shaping Presbyopia Correcting Intraocular Lens.

Authors:  Kjell Gunnar Gundersen; Richard Potvin
Journal:  Clin Ophthalmol       Date:  2021-12-19

6.  In Vitro Chromatic Performance of Three Presbyopia-Correcting Intraocular Lenses with Different Optical Designs.

Authors:  Diego Montagud-Martínez; Vicente Ferrando; Anabel Martínez-Espert; Salvador Garcia-Delpech; Juan A Monsoriu; Walter D Furlan
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

7.  Evaluation of Quality of Vision and Visual Outcomes with Bilateral Implantation of a Non-Diffractive Extended Vision Intraocular Lens with a Target of Slight Myopia in the Non-Dominant Eye.

Authors:  T Hunter Newsom; Richard Potvin
Journal:  Clin Ophthalmol       Date:  2022-01-25

8.  Long-Term Evaluation of Visual Outcomes and Patient Satisfaction after Binocular Implantation of a Bioanalogic Lens.

Authors:  Sylwia Wagner; Grzegorz Wagner; Ewa Mrukwa-Kominek
Journal:  J Ophthalmol       Date:  2021-05-07       Impact factor: 1.909

9.  Visual Performances of a New Extended Depth-of-Focus Intraocular Lens with a Refractive Design: A Prospective Study After Bilateral Implantation.

Authors:  Leopoldo Spadea; Maria Ilaria Giannico; Martina Formisano; Ludovico Alisi
Journal:  Ther Clin Risk Manag       Date:  2021-07-16       Impact factor: 2.423

10.  Multicountry clinical outcomes of a new nondiffractive presbyopia-correcting IOL.

Authors:  Chandra Bala; Francisco Poyales; Mercè Guarro; Ramón Ruiz Mesa; Ali Mearza; Devesh Kumar Varma; Srichand Jasti; Jessie Lemp-Hull
Journal:  J Cataract Refract Surg       Date:  2022-02-01       Impact factor: 3.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.